exp date isn't null, but text field is
Patients prescribed clozapine may decide to try and stop smoking prompted by concerns related to the Covid-19.
Our standard guidance recommends baseline and regular clozapine plasma level assays to support such quit attempts.
However in the current crisis undertaking such frequent plasma level monitoring will be impractical.
This guidance provides a pragmatic approach to support patients who wish to stop smoking during the pandemic.
If a patient prescribed clozapine is engaging in a managed quit attempt during the current pandemic take the following actions.
Ensure patients are advised to contact mental health services if they experience any new side effects or a worsening of existing side effects. Advise them to inform mental health services immediately if they resume smoking.
For further advice contact Leverndale Pharmacy, 01412116525.
This guidance will only apply for the duration of the Covid-19 pandemic.
Last reviewed: 14 April 2020
Next review: 01 April 2022
Approved By: PMG-MH
Reviewer Name(s): Lead Clinical Pharmacist, Clinical Effectiveness Pharmacist